FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Testosterone (Axiron) Solution
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism

Eli Lilly and Co. (New 09/12/2017)

Company Contact Information:
800-545-5979

Presentation Posting Date Related Information
Axiron 30mg/1.5ml (NDC 0002-1975-90)(NDC 0002-1975-61) and Authorized Generic Testosterone 30mg/1.5ml (NDC 66993-963-89) 09/12/2017 Discontinuation of the manufacture of the drug. This discontinuation is not related to safety or efficacy of drug. There are multiple commercial manufacturers currently supplying the US market.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English